Scientists at Rutgers and other universities build technology that could lead to rapid discovery of new medicines and biomarkers hidden in genomes
Discovering the function of a gene requires cloning a DNA sequence and expressing it. Until now, this was performed on a one-gene-at-a-time basis, causing a bottleneck. Scientists at Rutgers University-New Brunswick in collaboration with Johns Hopkins University and Harvard Medical School have invented a technology to clone thousands of genes simultaneously and create massive libraries of proteins from DNA samples, potentially ushering in a new era of functional genomics.
“We think that the rapid, affordable, and high-throughput cloning of proteins and other genetic elements will greatly accelerate biological research to discover functions of molecules encoded by genomes and match the pace at which new genome sequencing data is coming out,” said Biju Parekkadan, an associate professor in the Department of Biomedical Engineering at Rutgers University-New Brunswick.
In a study published online today in the journal Nature Biomedical Engineering, the researchers showed that their technology – LASSO (long-adapter single-strand oligonucleotide) probes – can capture and clone thousands of long DNA fragments at once.
As a proof-of-concept, the researchers cloned more than 3,000 DNA fragments from E. coli bacteria, commonly used as a model organism with a catalogued genome sequence available.
“We captured about 95 percent of the gene targets we set out to capture, many of which were very large in DNA length, which has been challenging in the past,” Parekkadan said. “I think there will certainly be more improvements over time.”
They can now take a genome sequence (or many of them) and make a protein library for screening with unprecedented speed, cost-effectiveness and precision, allowing rapid discovery of potentially beneficial biomolecules from a genome.
In conducting their research, they coincidentally solved a longstanding problem in the genome sequencing field. When it comes to genetic sequencing of individual genomes, today’s gold standard is to sequence small pieces of DNA one by one and overlay them to map out the full genome code. But short reads can be hard to interpret during the overlaying process and there hasn’t been a way to sequence long fragments of DNA in a targeted and more efficient way. LASSO probes can do just this, capturing DNA targets of more than 1,000 base pairs in length where the current format captures about 100 base pairs.
The team also reported the capture and cloning of the first protein library, or suite of proteins, from a human microbiome sample. Shedding light on the human microbiome at a molecular level is a first step toward improving precision medicine efforts that affect the microbial communities that colonize our gut, skin and lungs, Parekkadan added. Precision medicine requires a deep and functional understanding, at a molecular level, of the drivers of healthy and disease-forming microbiota.
Today, the pharmaceutical industry screens synthetic chemical libraries of thousands of molecules to find one that may have a medicinal effect, said Parekkadan, who joined Rutgers’ School of Engineering in January.
“Our vision is to apply the same approach but rapidly screen non-synthetic, biological or ‘natural’ molecules cloned from human or other genomes, including those of plants, animals and microbes,” he said. “This could transform pharmaceutical drug discovery into biopharmaceutical drug discovery with much more effort.”
The next phase, which is underway, is to improve the cloning process, build libraries and discover therapeutic proteins found in our genomes, Parekkadan said.
The Latest on: Precision medicine
- RTI International Announces Follow-On Investment in Precision Medicine Company PierianDXon November 14, 2019 at 8:38 am
RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2019 /PRNewswire/ -- RTI International (RTI), a leading research institute, today announced a follow-on investment in PierianDx, to help empower leading health ...
- A step closer to cancer precision medicineon November 14, 2019 at 7:36 am
Researchers from the Faculty of Medicine and the Institute for Molecular Medicine (FIMM) at the University of Helsinki have developed a computational model, Combined Essentiality Scoring (CES) that ...
- International study improves traumatic brain injury diagnosis with the use of precision medicineon November 13, 2019 at 6:25 am
The authors link these deficiencies in medical care to the traditional TBI classification, which is outdated. Faced with this method, which they consider ineffective, research suggests an approach to ...
- Precision Medicine Market Attain Valuation US$ 84 Billion by 2026on November 13, 2019 at 5:41 am
The global precision medicine market value is expected to reach around US$ 84 billion by 2026 growing at a CAGR of 10% in terms of revenue from 2019 to 2026. Precision medication (PM) is a form of ...
- Global Precision Medicine Market Primary and Secondary Research by Industry Size, Share, Trends, Key Players, Regions and Forecast 2025on November 12, 2019 at 3:46 am
Market Research Report on Global Precision Medicine Market with industry analysis and forecast 2019-2025 covers key players such as Johnson & Johnson, IBM, GE Healthcare, Illumina, Roche etc. QY ...
- Precision Medicine Market 2019 Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2024on November 7, 2019 at 10:22 pm
Nov 08, 2019 (The Expresswire) -- The Connected Precision Medicine Market 2019 research report offers the comprehensive analysis of the Precision Medicine Market size, covering an inside and out ...
- Study aims to use precision medicine to aid pulmonary fibrosis treatmenton November 5, 2019 at 2:49 pm
The Pulmonary Fibrosis Foundation is starting PRECISIONS, a study intended to transform the diagnosis and treatment of idiopathic pulmonary fibrosis through precision medicine. The study is supported ...
- Using Clinical Decision Support Tools To Facilitate Decision-Making In Precision Medicineon November 5, 2019 at 11:33 am
To fulfill its promise precision medicine requires accurate decision support tools, especially to streamline biomarker testing so that the appropriate targeted therapies are prescribed. Even in ...
- $22M NIH Grant Supports Precision Medicine for Pulmonary Fibrosison November 5, 2019 at 6:33 am
November 05, 2019 - The National Institutes of Health and Three Lakes Partners, a philanthropic family organization, has awarded the Pulmonary Fibrosis Foundation (PFF) a $22 million grant to support ...
- Precision Medicine Market Is Likely to Reach $7.74 Billion by 2023on November 5, 2019 at 3:33 am
“Surge in prevalence of cancer and rise increase in elderly population susceptible to diseases fuel the growth of the global precision medicine market.” The global precision medicine market is ...
via Google News and Bing News